Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRUST: Treat-to-Target vs Treat-to-Avoid Symptoms in Gout
NCT04875702Phase 4Recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Feb 2024
- Primary completion
- Sep 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of allopurinol in gout, sponsored by Massachusetts General Hospital. Started Feb 2024; status: recruiting.
02
Drugs
allopurinol
03
Conditions
gout
Beyond the preview
Go deeper on NCT04875702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04875702.